Kardiologia Polska

Papers
(The median citation count of Kardiologia Polska is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Left atrial strain — a current clinical perspective26
Short-term heart rate variability in resting conditions: methodological considerations20
Association between cardiovascular disease, cardiovascular drug therapy, and in-hospital outcomes in patients with COVID-19: data from a large single-center registry in Poland20
Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats19
The association of acute­-to­-chronic glycemic ratio with no-reflow in patients with ST­-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention19
Recording an isoelectric interval as an endpoint of left bundle branch pacing with continuous paced intracardiac electrogram monitoring18
Acute myocardial infarction in young patients17
Fibromuscular dysplasia: its various phenotypes in everyday practice in 202115
Telemedicine solutions in cardiology: a joint expert opinion by the Information Technology and Telemedicine Committee of the Polish Cardiac Society, the Section of Noninvasive Electrocardiology and Te15
An optimal chest compression technique using personal protective equipment during resuscitation in the COVID-19 pandemic: a randomized crossover simulation study14
Every rose has its thorns — acute myocarditis following COVID-19 vaccination13
Effect of a mobile application and smart devices on heart rate variability in diabetic patients with high cardiovascular risk: A sub-study of the LIGHT randomized clinical trial13
Pulmonary embolism response team: A multidisciplinary approach to pulmonary embolism treatment. Polish PERT Initiative Report12
Transesophageal echocardiography for the monitoring of transvenous lead extraction12
Prevalence of atrial fibrillation in the 65 or over Polish population. Report of cross-sectional NOMED-AF study12
Hypersensitivity myocarditis and COVID-19 vaccines11
MicroRNA 1283 alleviates cardiomyocyte damage caused by hypoxia /reoxygenation via targeting GADD45A and inactivating the JNK and p38 MAPK signaling pathways11
Thromboembolism and bleeding in patients with atrial fibrillation and stage 4 chronic kidney disease: impact of biomarkers11
Prognostic value of the triglyceride-glucose index among non-diabetic patients with acute myocardial infarction at one-year follow-up10
COVID-19 and thrombosis: Clinical features, mechanism of disease, and therapeutic implications10
The effect of 1-year mean step count on the change in the atherosclerotic cardiovascular disease risk calculation in patients with high cardiovascular risk: a sub-study of the LIGHT randomized clinica10
Feasibility of the intravascular lithotripsy in coronary artery disease. Short-term outcomes of the Lower-Silesia Shockwave Registry10
Comparison of the real-life clinical outcomes of warfarin with effective time in therapeutic range and non-vitamin K antagonist oral anticoagulants: Insight from the AFTER-2 trial9
Efficacy and safety of coronary computed tomography angiography in patients with a high clinical likelihood of obstructive coronary artery disease9
Transcatheter patent ductus arteriosus closure: what have we learned after over 25 years? A single-­center experience with 1036 patients9
Risks associated with intensive blood pressure control in older patients9
Patients scheduled for TAVI tend to form abnormal fibrin clots more resistant to lysis: the impact of age9
Patent foramen ovale and left atrial appendage flow velocity predict atrial fibrillation recurrence post cryoballoon ablation9
The impact of a dedicated coronavirus disease 2019 primary angioplasty protocol on time components related to ST‑segment elevation myocardial infarction management in a 24/7 primary percutaneous coron9
Protamine sulfate during transcatheter aortic valve implantation (PS TAVI) — a single-center, single-blind, randomized placebo-controlled trial9
The effect of exercise training and physiotherapy on diastolic function, exercise capacity and quality of life in patients with heart failure with preserved ejection fraction: a systematic review 9
Management and predictors of clinical events in 75 686 patients with acute myocardial infarction8
Intraosseous versus intravenous access while wearing personal protective equipment: a meta-analysis in the era of COVID-198
Left bundle branch pacing in patients with right bundle branch block8
A practical approach to the 2022 ESC cardio-oncology guidelines: Comments by a team of experts – cardiologists and oncologists8
D-dimer levels predict COVID-19 severity and mortality8
Acute myocarditis associated with the Pfizer/BioNTech vaccine8
Diabetes mellitus as a risk factor for aortic stenosis: from new mechanisms to clinical implications8
Specific characteristics of STEMI in COVID-19 patients and their practical implications8
A new approach of statin therapy in carotid atherosclerosis: Targeting indices of plaque vulnerability on the top of lipid-lowering. A narrative review8
Comprehensive cardiac rehabilitation as the keystone in the secondary prevention of cardiovascular disease7
How to identify anthracycline-induced cardiotoxicity early and reduce its clinical impact in everyday practice7
Use of cardiac troponin in the early diagnosis of acute myocardial infarction7
The burden of cardiovascular risk factors among seniors with congenital heart disease: A single tertiary center experience7
SGLT2 inhibitors and the risk of urinary tract infections in patients with heart failure: A pooled analysis examining safety endpoints7
Comparison of the short-term safety and efficacy of transcarotid and transfemoral access routes for transcatheter aortic valve implantation7
Invasive assessment of coronary microvascular dysfunction in patients with long COVID: Outcomes of a pilot study7
Dyslipidemia treatment and attainment of LDL-cholesterol treatment goals in patients participating in the Managed Care for Acute Myocardial Infarction Survivors program7
Syncope: new solutions for an old problem7
Incidence of mechanical complications following myocardial infarction during the first two months of the COVID-19 pandemic in the Southern Poland region: a multicenter study7
Role of catheter-directed therapies in the treatment of acute pulmonary embolism. Expert opinion of the Polish PERT Initiative, Working Group on Pulmonary Circulation, Association of Cardiovascular In7
Cost-effectiveness of telerehabilitation in patients with heart failure in Poland: an analysis based on the results of the Telerehabilitation in Heart Failure Patients (TELEREH-HF) randomized clinical7
PCSK9 inhibitors and reduction in cardiovascular events: Current evidence and future perspectives7
Sex-related differences and rotational atherectomy: Analysis of 5 177 percutaneous coronary interventions based on a large national registry from 2014 to 20207
Correlations between left atrial strain and left atrial pressures values in patients undergoing atrial fibrillation ablation7
Interventions of emergency medical teams in Poland during the SARS-CoV-2 pandemic7
The diagnosis and management of spontaneous coronary artery dissection — expert opinion of the Association of Cardiovascular Interventions (ACVI) of Polish Cardiac Society6
CHA2DS2-VASc score as a predictor of no-reflow phenomenon after saphenous vein graft percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndromes6
Analysis of 75 consecutive COVID-19 ECMO cases in Warsaw Centre for Extracorporeal Therapies6
Randomized clinical trials of patients with acute myocardial infarction-related cardiogenic shock: a systematic review of used cardiogenic shock definitions and outcomes6
Anthracycline-induced microcirculation disorders: AIM PILOT Study6
Clinical use of intracoronary imaging modalities in Poland. Expert opinion of the Association of Cardiovascular Interventions of the Polish Cardiac Society6
Dual pathway inhibition for atherosclerotic cardiovascular disease: Recent advances6
Cardiovascular disease in asthma patients: From mechanisms to therapeutic implications6
Can sodium glucose cotransporter 2 (SGLT-2) inhibitors be beneficial in patients with acute myocardial infarction?6
Association between endometriosis and increased arterial stiffness6
Sacubitril/valsartan as first-line therapy in anthracycline-induced cardiotoxicity6
Survival analysis of patients with acute coronary syndrome receiving comprehensive coordinated care after myocardial infarction (KOS-Zawał)6
The association between whole blood viscosity and high thrombus burden in patients with non-ST elevation myocardial infarction6
Optimal anticoagulation in elderly patients with atrial fibrillation: Which drug at which dose?6
Low-grade endotoxemia and NOX2 in patients with coronary microvascular angina6
Long-term clinical follow-up of the resorbable magnesium scaffolds in acute coronary syndrome patients6
Neopterin as a predictive biomarker of postoperative atrial fibrillation following coronary artery bypass grafting5
Role of cardiac magnetic resonance in heart failure of initially unknown etiology: A 10-year observational study5
The burden of cardiovascular disease risk factors: A current problem5
Gut dysbiosis-derived low-grade endotoxemia: A common basis for liver and cardiovascular disease5
Validity of the Pneumonitor for RR intervals acquisition for short-term heart rate variability analysis extended with respiratory data in pediatric cardiac patients5
Recent advances in the pharmacotherapy of pulmonary hypertension: practical considerations5
Noncardiovascular comorbidities in patients with heart failure and their impact on prognosis5
Is neural network better than logistic regression in death prediction in patients after ST-segment elevation myocardial infarction?5
Mavacamten — a new disease-specific option for pharmacological treatment of symptomatic patients with hypertrophic cardiomyopathy5
Non-invasive right ventriculo-arterial coupling as a rehospitalization predictor in dilated cardiomyopathy: A comparison of five different methods5
How to treat incidental pulmonary embolism in cancer patients? Recent advances5
Percutaneous left atrial appendage occlusion in the current practice5
Risk factors of cardiac insufficiency in children with multisystem inflammatory syndrome and COVID-19: A prospective cohort study5
The usefulness of telemedicine devices in patients with severe heart failure with an implanted cardiac resynchronization therapy system during two years of observation5
Direct oral anticoagulants in patients with atrial fibrillation following bariatric surgery: A single center experience5
Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario5
Efficacy of coronary sinus reducer implantation in patients with chronic total occlusion of the right coronary artery5
Role of global longitudinal strain in evaluating radiotherapy--induced early cardiotoxicity in breast cancer: A meta-analysis5
Clinical and linguistic validation of a Polish version of the Pulmonary Embolism Quality of Life Questionnaire: a disease-specific quality of life questionnaire for patients after acute pulmonary embo5
Intravascular ultrasound for transcatheter pulmonary valve replacement5
Chronotropic incompetence causes multiple organ complications in adults after the Fontan procedure5
Risk of perioperative death and sudden cardiac arrest: A study of 113 456 cases from the National Registry of Invasive Cardiology Procedures (ORPKI) for estimation of the perioperative prognosis5
Radiation therapy in patients with cardiac implantable electronic devices4
Long-term outcomes in patients after left atrial appendage occlusion: The results from the LAAO SILESIA registry4
Efficacy and safety of the Amplatzer Duct Occluder II for ventricular septal defect closure: a meta-analysis4
Characteristics of patients from the Polish Registry of Acute Coronary Syndromes during the COVID-19 pandemic: the first report4
Cardiac magnetic resonance imaging with T2 mapping for the monitoring of acute heart transplant rejection in patients with problematic endomyocardial biopsy: in anticipation of new recommendations4
Frequency and predictors of diagnostic coronary angiography and percutaneous coronary intervention related to stroke4
How to predict prognosis in patients with acute pulmonary embolism? Recent advances4
Percutaneous coronary intervention of a tortuous and complex circumflex lesion using the robotic CorPath GRX system4
Right atrial phasic function and outcome in patients with heart failure and reduced ejection fraction: Insights from speckle-tracking and three-dimensional echocardiography4
Position of the Polish Cardiac Society on therapeutic targets for LDL cholesterol concentrations in secondary prevention of myocardial infarctions4
A randomized comparison of HBP versus RVP: Effect on left ventricular function and biomarkers of collagen metabolism4
Periodontitis as an inflammatory trigger in hypertension: From basic immunology to clinical implications4
New approaches to achieving hemostasis after venous access in cardiovascular patients4
Diagnostic and prognostic performance of the neutrophil-to-lymphocyte ratio in acute coronary syndromes: A meta-analysis of 90 studies including 45 990 patients4
Managed Care after Acute Myocardial Infarction (MC-AMI) improves prognosis in AMI survivors with pre-existing heart failure: A propensity score matching analysis of Polish nationwide program of compre4
Radiation-induced cardiac dysfunction: Practical implications4
Navitor valve — a new TAVI solution for patients with aortic stenosis4
Tetralogy of Fallot in the fetus — from diagnosis to delivery. 18-year experience of a tertiary Fetal Cardiology Center4
Direct oral anticoagulants in patients with atrial fibrillation and liver cirrhosis: a single-center experience4
Incidence and course of acute coronary syndrome cases after the first wave of the COVID-19 pandemic4
Predictors and mid-term outcomes of nosocomial infection in ST-elevation myocardial infarction patients treated by primary angioplasty4
Assessment of the Willis circle flow changes and the severity of degenerative aortic stenosis and cognitive impairment4
The prevalence and association of major ECG abnormalities with clinical characteristics and the outcomes of real-life heart failure patients — Heart Failure Registries of the Eu ropean Society of C4
Malignant arrhythmia associated with mitral annular disjunction: Myocardial work as a potential tool in the search for a substrate4
Low levels of vitamin D and coronary artery disease: Is it time for therapy?4
Left ventricular noncompaction cardiomyopathy: Recent advances4
An expert opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation on screening for chronic thromboembolic pulmonary hypertension patients after acute pulmonary embolism: Update4
Potential renoprotective effect of SGLT2 inhibitors against contrast-induced AKI in diabetic STEMI patients undergoing primary PCI4
Pulmonary function and quality of life after aortic valve replacement through ministernotomy: a prospective randomized study4
Expression of versican mRNA transcript to predict cardiac remodelling after myocardial infarction4
Challenges in the remote monitoring of cardiac implantable electronic devices in 20214
Knowledge on the guideline-recommended use of antiplatelet and anticoagulant therapy during dental extractions: a contemporary survey among Polish dentists4
The surprising course of multiple sclerosis relapse in a patient after SARS-CoV-2 vaccination4
Diagnostic yield is dependent on monitoring duration. Insights from a full-disclosure mobile cardiac telemetry system4
Novel biomarkers and emerging tools to identify causal molecular pathways in hypertension and associated cardiovascular diseases4
Comparison of fusion imaging and two-dimensional angiography to guide percutaneous pulmonary vein interventions3
Aortic regurgitation and left ventricle remodeling on cardiac magnetic resonance and transthoracic echocardiography3
Predictors of mortality and cardiovascular outcomes in Emery-Dreifuss muscular dystrophy in a long-term follow-up3
Is cytisine contraindicated in smoking patients with coronary artery disease after percutaneous coronary intervention?3
The importance of the longest R-R interval on 24-hour electrocardiography for mortality prediction in patients with atrial fibrillation3
Sex- and gender‑specific precision medicine for chronic coronary syndromes: challenges and opportunities3
Accelerometer-measured light-intensity physical activity and the risk of cardiovascular disease or death in older adults: A meta-analysis3
Fatty acids and aortic valve stenosis3
Multimodality imaging and hybrid treatment of pulmonary artery stenosis in a patient with high risk of airway compression3
Aortic dissection after the Ross procedure3
Cerebral embolic protection in patients undergoing transcatheter aortic valve implantation: Recent advances3
3D reconstruction for preoperative planning of partial anomalous pulmonary venous return3
Fetal echocardiography is not only used to detect congenital heart disease but also to monitor fetuses, especially those with different pathologies3
Advanced imaging in interventional cardiology: mixed reality to optimize preprocedural planning and intraprocedural monitoring3
Emerging nuclear medicine modalities to improve diagnostic accuracy in myocarditis3
Very long-term follow-up of patients with coronary bifurcation lesions treated with bioresorbable scaffolds3
Clinical report of 8 families with atrioventricular nodal reentrant tachycardia from China3
Effectiveness of surgical closure of left atrial appendage during minimally invasive mitral valve surgery3
Metabolic associated fatty liver disease and cardiovascular risk: The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society3
Unique family clustering of anomalous left main coronary artery origin from the right sinus of Valsalva: a case for echocardiographic screening and genetic determination3
Smoking cessation in patients with established coronary artery disease: data from the POLASPIRE survey3
Reaching the left bundle branch pacing area within 36 heartbeats3
Biomarkers of left atrial overload in obese and nonobese patients with atrial fibrillation qualified for electrical cardioversion3
Headache after transcatheter closure of atrial septal defect: An attempt to explain its origin in the pediatric population3
The Revised Self-Care of Heart Failure Index — a new tool for assessing the self-care of Polish patients with heart failure3
Magnetic resonance imaging in patients with cardiac implantable electronic devices in a cardio-oncology center3
Management of valvular heart disease in patients with cancer: Multidisciplinary team, cancer-therapy related cardiotoxicity, diagnosis, transcatheter intervention, and cardiac surgery. Expert opini3
Left atrial longitudinal strain in the contractile phase as a predictor of sinus rhythm maintenance after electrical cardioversion performed due to persistent atrial fibrillation3
Aborted myocardial infarction in patients with ST-segment elevation myocardial infarction treated with mechanical reperfusion3
Right ventricular wall thickness indexed to body surface area as an echocardiographic predictor of acute pulmonary embolism in high-risk patients3
Pharmacotherapy of heart failure A.D. 2023. Expert opinion of Working Group on Cardiovascular Pharmacotherapy, Polish Cardiac Society3
Total arterial revascularization coronary artery bypass surgery in patients with atrial fibrillation3
Coronary Sinus Reducer implantation in refractory angina: Short-term outcomes based on the Lower Silesia Sinus Reducer Registry (LSSRR)3
Optimal anticoagulation in patients with atrial fibrillation and bioprosthetic heart valves3
Left atrial geometric and functional remodeling parameters measured by cardiac magnetic resonance imaging and outcome prediction in patients with severe aortic stenosis3
Sudden cardiac arrest: Focus on cardiac magnetic resonance3
Intravascular lithotripsy for the treatment of a heavily calcified recurrent in-stent restenosis in patient with chronic coronary syndrome3
Outcome comparison of different approaches to aortic root aneurysm3
Acetylcholine provocation test with resting full-cycle ratio, coronary flow reserve, and index of microcirculatory resistance give definite answers and improve health-related quality of life3
Two-­year prognosis of patients hospitalized for decompensated heart failure in a district general hospital3
Fetal foramen ovale flap tracings, as determined by M-mode echocardiography between weeks 24 and 39 of gestation3
Acute heart failure in the course of fulminant myocarditis requiring mechanical circulatory support in a healthy young patient after COVID-193
Is anthracycline-induced heart failure reversible?3
Comparison of clinical characteristics, in-hospital course, and 12-month prognosis in women and men with chronic coronary syndromes3
New hope for patients and challenges for the multidisciplinary arrhythmia team: a hybrid convergent approach for atrial fibrillation treatment3
Expert opinion of the Heart Failure Working Group of the Polish Cardiac Society on the use of dapagliflozin in the treatment of heart failure with reduced ejection fraction3
Long-term benefits and risks in patients after persistent foramen ovale closure: a contemporary approach to guide clinical decision making3
Does the presence of physician-staffed emergency medical services improve the prognosis in out-of-hospital cardiac arrest? A propensity score matching analysis3
Factors affecting short- and long-term survival of patients with acute coronary syndrome treated invasively using intravascular ultrasound and fractional flow reserve: Analysis of data from the Pol3
Complex cardiovascular defects in a male infant with Williams syndrome juxtaposed with the results of a preliminary survey illustrating other patients’ outcomes3
Rationale and design of XARENO: XA inhibition in RENal patients with non-valvular atrial fibrillation. Observational registry3
Screening for atrial fibrillation: Different approaches targeted to reduce ischemic stroke3
Aortic dissection four months after SARS-CoV-2 infection in a patient with Fabry disease whose targeted treatment was stopped 2 months earlier3
Atrial fibrillation post-coronary or cardiac surgery: A transient inflammation-related event or the expression of a pre-existing arrhythmogenic atrial substrate?3
Endothelial function in patients with critical and non-critical limb ischemia undergoing endovascular treatment3
A distinct septal pattern of late gadolinium enhancement specific for COVID-induced myocarditis: A multicenter cardiovascular magnetic resonance study3
Fragmented QRS and arrhythmic events in patients with implantable cardioverter-defibrillators3
Mechanical circulatory support. An expert opinion of the Association of Intensive Cardiac Care and the Association of Cardiovascular Interventions of the Polish Cardiac Society3
Relationship between systemic inflammation indices and time of symptom onset in cardiac remodeling after first ST-segment elevation myocardial infarction3
Perivascular adipose tissue from the internal mammary artery in patients with severe coronary artery atherosclerosis3
Virtual reality for transcatheter procedure planning in congenital heart disease3
An expert opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation and the Polish Society for Rheumatology on the diagnosis and treatment of pulmonary hypertension in patients with3
Mortality risk assessment in dilated cardiomyopathy: the Krakow DCM Risk Score3
Biomarkers in atrial fibrillation: a constant search for simplicity, practicality, and cost-effectiveness3
People who survived their death. Advice for medical professionals based on the analysis of published cases worldwide3
Carotid artery stenosis in asymptomatic patients undergoing coronary artery bypass grafting: who and when should be screened?3
Nonuniform expansion of the LOTUS Edge intra-annular transcatheter aortic valve seen on intravascular ultrasound as a mechanism of prosthesis–patient mismatch3
Association of serum sclerostin levels with atherosclerosis severity in patients referred for invasive coronary angiography3
Extremely high-risk patients with acute coronary syndrome: How “extreme” should lipid-lowering therapy be if the LDL-C target <40 mg/dl is considered?3
A prospective case-control validation of procalcitonin as a biomarker diagnosing pacemaker and implantable cardioverter-defibrillator pocket infection2
Biomarkers for atrial fibrillation and chronic kidney disease: what is the evidence?2
The impact of chronic alcohol overuse on heart function and prognosis: layer-specific longitudinal strain and mid-term outcome analysis2
Coronary microvascular dysfunction in the context of long COVID-19: What is the effect of anti-inflammatory treatment?2
Summary of the European Society of Cardiology guidelines on dual antiplatelet therapy in patients after percutaneous coronary interventions2
Resting heart rate is associated with novel plasma atherosclerosis biomarkers2
Permanent cardiac arrest in a patient with a left ventricular assist device support2
The impact of operator experience on the success rate, time aspects, and electrocardiographic features in left bundle branch area pacing2
Cardiovascular disease in women: Do we need new diagnostic and therapeutic strategies?2
Feasibility and safety of left bundle branch area pacing in very elderly patients (≥80 years)2
Supracardiac partial anomalous pulmonary venous connection recognized by computed tomography in an adult patient2
Optical coherence tomography enhanced by novel software to better visualize the mechanism of atherosclerosis and improve the effects of percutaneous coronary intervention2
Biventricular assist device–induced recovery from acute heart failure in peripartum cardiomyopathy on cardiac magnetic resonance imaging2
Fever-induced type-1 Brugada pattern: A sign of revealed Brugada syndrome or just a Brugada phenocopy?2
Statin therapy for primary cardiovascular prevention in adults older than 75 years2
Long-term efficacy of dabigatran in heparin-induced thrombocytopenia (HIT) after off-pump coronary artery bypass surgery2
Association between Intermountain Risk Score and long-term mortality with the transcatheter aortic valve implantation procedure2
Influence of increased arterial stiffness on myocardial work efficiency in patients with stable coronary artery disease2
Quality of life in patients with a subcutaneous vs. transvenous implantable cardioverter-defibrillator2
Clinical characteristics of Kawasaki disease in Polish children: A retrospective study2
Unusual finding during screening for intracardiac thrombus in patients referred for percutaneous left atrial appendage closure2
The increase of the pulmonary blood flow in hypoxic, high-risk patients with bidirectional Glenn anastomosis2
Thoracic endovascular aortic repair: Current evidence and challenges2
The use of GLP-1 analogues in the treatment of diabetes in patients with cardiovascular diseases. The expert opinion of the Working Group of Cardiovascular Pharmacotherapy of the Polish Cardiac Societ2
High-density lipoprotein cholesterol, triglycerides, and characteristics of coronary atherosclerosis in patients with significant coronary artery disease newly diagnosed by computed tomography coro2
Expert opinion of the Heart Rhythm Association of the Polish Cardiac Society and the Polish Neurological Society on evidence-driven implementation of implantable loop recorders in Poland2
Cardiac paraganglioma: A challenging diagnostic and treatment dilemma2
Aneurysm of the aortic root and valve‑sparing aortic root replacement: long-term outcomes from a single Polish center2
Patient perspective and safety of remote monitoring of implantable cardioverter-defibrillators in the Polish Nationwide Multicenter Registry: the Medtronic CareLink network evaluation2
A simplified acute kidney injury predictor following transcatheter aortic valve implantation: the ACEF score2
Factors determining the frequency of optical coherence tomography and intravascular ultrasound use in patients treated with percutaneous coronary interventions in recent years: Analysis based on a lar2
How to predict conduction disturbances after transcatheter aortic valve replacement2
Orbital-Tripsy — orbital atherectomy facilitated by Shockwave Intravascular Lithotripsy: Novel bailout strategy in percutaneous coronary intervention in heavily calcified coronary lesions2
Long-term outcomes following drug-eluting balloons vs. thin-strut drug-eluting stents for treatment of recurrent restenosis in drug-eluting stents2
The course and treatment of COVID-19 in heart transplant recipients: A case series from the late phase of the pandemic2
Percutaneous coronary intervention to treat unprotected left main: Common (un-answered) challenges2
Orbital atherectomy for treatment of calcified coronary artery lesions. First experiences in Poland: Short-term outcomes of the Lower-Silesia Orbital Atherectomy Registry (LOAR)2
Perivascular adipose tissue as the secret behind resistance to atherosclerosis exhibited by the human internal mammary artery2
Three varieties of sense-B-noise, a novel cause of inappropriate shocks in patients treated with a subcutaneous cardioverter-defibrillator2
Risk factors of contrast-induced nephropathy in patients with acute coronary syndrome2
Public interest in cardiac arrest after Christian Eriksen’s mid-football-game event was acute rather than chronic: The analysis of Google search trends2
Impact of diabetes mellitus on the diagnostic performance of fractional flow reserve in patients with severe aortic stenosis2
Operative management after transcatheter aortic valve replacement2
Hypertrophic cardiomyopathy and anomalous origin of the left coronary artery: a rare coexistence2
Impact of the COVID-19 pandemic on the performance of selected cardiac electrotherapy and electrophysiology procedures2
Expert opinion of the Working Group on Leadless Pacing appointed by the National Consultant in Cardiology and the Board of the Heart Rhythm Section of the Polish Cardiac Society2
Cardiological teleconsultation in the coronavirus disease 2019 era: patient’s and physician’s perspective2
Cardioneuroablation for the treatment of vagally mediated atrial fibrillation and vasovagal syncope2
The effect of a dynamic increase in afterload on the first-phase ejection fraction2
Identification of noncalcified coronary plaque characteristics using machine learning radiomic analysis of non-contrast high-resolution computed tomography2
Percutaneous tricuspid edge-to-edge repair — patient selection, imaging considerations, and the procedural technique. Expert opinion of the Working Group on Echocardiography and Association of CardioV2
Incidental diagnosis of Brugada syndrome in two girls hospitalized for pediatric inflammatory multisystem syndrome related to COVID-19 (PIMS-TS)2
0.034002065658569